Bacitracin
NDC Package 17478-608-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Bacitracin is a medication an antibiotic used to treat certain bacterial eye infections. Marketed by Akorn, this product is identified by NDC 17478-608 and is authorized under FDA application ANDA206719.

Identification & Billing

NDC Package Code
17478-608-30
Package Description
1 VIAL in 1 CARTON / 10 mL in 1 VIAL
Product Code
11-Digit Billing Format
17478060830

Clinical Specifications

Proprietary Name
Bacitracin
Dosage Form
-
Usage Information
This medication is an antibiotic used to treat certain bacterial eye infections. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

Regulatory & Marketing

Labeler Name
Akorn
FDA Application #
ANDA206719
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
10-23-2017
End Marketing Date
10-24-2017
Listing Expiration
10-24-2017
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 17478-608-30 identifies a specific commercial package of 1 vial in 1 carton / 10 ml in 1 vial of Bacitracin, labeled by Akorn. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Akorn on October 23, 2017. The current certification is valid through October 24, 2017.

What are the primary indications for this medication?

This medication is an antibiotic used to treat certain bacterial eye infections. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

How is this Akorn product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 17478060830. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
17478-608-30
11-Digit CMS (5-4-2)
17478-0608-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.